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Summary.-The serum ferritin concentration is increased in both acute myeloblastic
leukaemia and Hodgkin's disease. In acute leukaemia the mean concentration is
about ten times the normal level and is associated with a high concentration of
transferrin-bound iron. In Hodgkin's disease abnormal ferritinaemia is associated
with a low concentration of transferrin-bound iron and appears to result from a
block of reticuloendothelial iron release. Increased concentrations of circulating
ferritin have also been observed in a few cases of chronic leukaemia and myeloma-
tosis.
PREVIOUS studies ofcirculating ferritin
in malignant disease have used relatively
crude assay methods and it was thought
that this protein appeared only in patho-
logical circumstances. However, the
recent introduction of a sensitive assay
technique has shown that it is a normal
constituent of the circulating plasma,
although present only in very small
amounts (Addison et al., 1972; Jacobs
etal., 1972). Theleukaemias andlympho-
mata are associated with profound distur-
bances of erythropoiesis and iron meta-
bolism, and the present investigation was
made to determine the effect of these on
circulating ferritin.
In an early study Reissman and
Dietrich (1956) found persistent ferri-
tinaemia in 6 patients with Hodgkin's
disease involving the liver. In contrast,
no ferritin was found in the serum of 2
patients with sarcoidosis of the liver or 3
patients with carcinomatosis involving the
liver. Fourteen patients with proven
Hodgkin's disease but no evidence of
liver involvement were observed for over
a year and in none of these was ferritin
detected in the serum. Although these
authors attributed high levels of circu-
lating ferritin in Hodgkin's disease to the
accompanying acute hepatocellular necro-
sis, it was acknowledged that this was not
an entirely satisfactory explanation as
the ferritinaemia was unusually high and
persistent in relation to the limited extent
of the cellular necrosis. In addition, it
differed from the ferritinaemia found to
accompany acute liver disease in that it
was not associated with a rise in trans-
ferrin-bound iron. W6hlers and Schonlau
(1959) also found ferritinaemia in patients
with Hodgkin's disease but only in those
who had had radiotherapy. They also
noted ferritin in the serum of patients
with acute myeloid leukaemia.
Aungst (1968) used an immunological
gel diffusion method which was sensitive
to 100 ng ferritin protein/ml for the detec-
tion of ferritin in order to determine
whether the appearance of small amounts
of ferritin in the serum could serve as an
indicator ofhepatic involvement by malig-
nant tissue. He did not detect ferritin in
the serum of healthy subjects but found
high concentrations in patients with a
large variety of both malignant and non-
malignant conditions. All of 30 patients
with Hodgkin's disease and 15 of 21
patients with other malignant lympho-
mata had ferritin in their serum. Many
of these had hepatomegaly and abnormal
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The immunoradiometric assay for
ferritin used in the present study is
sensitive to a concentration of 0 2 ng
ferritin protein/ml and this has enabled a
comparison to be made between the serum
levels of ferritin in leukaemia and Hodg-
kin's disease and those in normal subjects.
PATIENTS AND METHODS
1. Thirty-five adults with untreated
acute myeloblastic leukaemia. The range
of values for haematological data were:
Haemoglobin 2 6-119 (mean 8.3) g/100 ml;
total leucocyte count 800-252,000 (mean
33,393) cells/1ul; platelets 12,000-96,000 (mean
44,878)/y1; serum iron 40-282 (mean 139)
ltg/100 ml; transferrin saturation 20-100
(mean 62)%. Eighteen of these patients
had a total white cell count of less than
10,000/1A.
2. Nineteen patients with untreated
Hodgkin's disease. Seven patients were in
clinical Stage I, 3 in Stage II, 5 in Stage I1I
and 4 in Stage IV (Carbone et al., 1971).
Haemoglobin 7-2-15-8 (mean 12.5) g/100 ml;
serum iron 20-128 (mean 49) ytg/100 ml; trans-
ferrin saturation 7-34 (mean 15-3)oo. The
differences in these parameters in Stages
I-IV were not significant. Similarly, the
mean haemoglobin concentration of 13 1
g/100 ml and the mean serum iron concen-
tration of 54 8 ,ug/100 ml in patients with no
systemic symptoms (Carbone et al., 1971)
did not differ significantly from those of
11 l g/l00 ml and 37 ,ug/lOO ml respectively
in patients with systemic symptoms. All
patients had stainable iron in sectioned
fragments of aspirated bone marrow.
3. Six untreated patients with non-
Hodgkin's lymphoma (4 with lymplhosarcoma
and 2 with reticulum cell sarcoma). Haemo-
globin 11-6-14-9 (mean 13 1) g/LOOml;
serum iron 22-152 (mean 68) ttg/100 ml;
transferrin saturation 6-38 (mean 19)%.
4. Seven patients with untreated chronic
lymplhatic leukaemia. Haemoglobin 8-6-14-8
(mean 11-7) g/100 ml; serum iroin 32-110
(mean 67) )g/100 ml; transferrin saturation
5-34 (mean 21)0%; total leucocyte count
23,000-220,000 (mean 87,000) cells/1A.
5. Three patients with untreated chronic
granulocytic leukaemia. Haemoglobin con-
centration 11-2-120 (mean 11 5) g/1(00 ml,
serum iron 70-136 (mean 105) ,ug/100 ml,
transferrin saturation 24-45 (mean 32) 0, total
white count 124,000-282,000 (mean 177,000)
cells/Ul.
6. Four patients with untreated myelo-
matosis. Haemoglobin 3-7-11-6 (mean 8-5)
g/100 ml; serum iron 54-85 (mean 76) jug/
100 ml; transferrin saturation 24-33 (mean
28)00.
Standard haematological techniques
were used (Dacie and Lewis, 1968). Serum
iron concentrations were determined by the
method of Young and Hicks (1965) and total
iron binding capacity using magnesium
carbonate as an adsorbent. Ferritin concen-
trations were measured by the immunoradio-
metric assay of Addison et al. (1972).
RESULTS
Serum ferritin concentrations for all
groups of patients are shown in Table I
TABLE I.-Serum Ferritin Concentration
(ng per mnl) in Normal Subjects and
Those with Leukaemia or Hodgkin's
Disease
Subjects
Normal men
Normal women
Acute myeloblastic
leukaemia
Hodgkin's disease
Non-Hodgkin's
lymphoma
Chronic granulocytic
leukaemia
Chronic lymphatic
leukaemia
MIyelomatosis
No.
75
44
35
MAean
69±5- 2
34±5 - 1
589± 66
Range
6-186
3-162
155-2200
19 215±44 66-720
6 61± 10 :33-90
3 278±15-9 250-305
7 234± 114 25-880
4 336± 162 73-800
together with the normal values found in a
previous study (Jacobs et al., 1972). The
mean ferritin concentration of patients
with acute myeloblastic leukaemia is
about 10 times normal and the highest
value was 2,200 ng/ml compared with the
highest normal value of 186 ng/ml. There
was no correlation between the serum
ferritin concentration in these patients
and haemoglobin concentration or platelet
count. There was, however, a significant
correlation with total white cell count
(Fig. 1), r 0 49, P < 0 005. While
patients with acute myeloblastic leukaemia
showed no statistical correlation between
serum ferritin concentration and either
seruim iron concentration or transferrin
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saturation, all these parameters were
higher than normal (Fig. 2).
The serum ferritin concentration is
increased in patients with Hodgkin's
disease, though not to the extent found in
acute myeloblastic leukaemia. Most of
the patients in this study had low serum
iron concentrations and low transferrin
saturations and the relationship found
between these values and the ferritin
concentration was quite different from
that found in acute myeloblastic leukaemia
(Fig. 2). Ferritin concentrations did not
vary significantly with clinical staging,
the mean value in Stages I and II being
195 ± 157 ng/ml and that in Stages III
and IV 238 i 69 ng/ml. The mean fer-
ritin concentration in patients of all
stages with no systemic manifestations
was 136-7 ± 26 ng/100 ml and those with
symptoms of systemic disease had a mean
ferritin concentration of 385 ± 98-5 ng/ml
(P < 0.05). None of the 6 patients with
non-Hodgkin's lymphoma had abnormal
concentrations of circulating ferritin.
Five of 7 patients with chronic
lymphatic leukaemia had a serum ferritin
concentration within the normal range.
The other 2 had values of 323 and 880
ng/ml respectively. These 2 cases did
not appear to differ from the other, either
clinically or haematologically. Similarly,
2 of the 4 patients with myelomatosis
who were examined had normal serum
ferritin concentrations whereas 2 had con-
centrations of 312 and 800ng/ml respec-
tively.
DISCUSSION
The association ofanaemia with malig-
nant disease has been known for a very
long time. Cartwright and Lee (1971)
point out that this anaemia has charac-
teristics similar to that found in chronic
infections, rheumatoid arthritis and colla-
gen diseases andreferto it as the " anaemia
of chronic disorders". Thev point out
that it is usually mild in degree and is
characterized by a decrease in plasma iron
concentration, a decreased total iron
binding capacity of the plasma and a
decreased transferrin saturation together
with a normal or increased reticulo-
endothelial iron. They suggest that a
more descriptive title might be " sider-
openic anaemia with reticuloendothelial
siderosis". They define 3 factors in the
pathogenesis of this anaemia: firstly, a
shortened red cell survival, secondly,
impaired marrow response to anaemia and
thirdly an impaired flow of iron from
reticuloendothelial cells into the plasma
for erythropoiesis. The impairment of
iron release by the reticuloendothelial
system has been referred to as the RE
iron block and this has been demonstrated
in a number of conditions (Beamish et al.,
1971). An investigation of iron meta-
bolism in 23 untreated patients with
Hodgkin's disease and 6 patients with
other lymphomata showed that the reduc-
tion in red cell life span is related to the
stage of the disease (Beamish et al., 1972).
There is impairment ofreticuloendothelial
iron release in all stages of the disease
and it was considered that the consequent
sideropenia resulted in a failure of iron
delivery to the bone marrow.
The anaemia associated with acute
leukaemia differs from that found in
Hodgkin's disease. There does not appear
to be an RE block in iron release and
serum iron concentrations are generally
higher than normal. Transferrin satura-
tion is usually increased (Caroline, Rosner
and Kozinn, 1969). The reason for the
increased serum iron concentration is not
clear but may be associated with defective
erythropoiesis in many cases (Nathan
and Berlin, 1959).
The serum ferritin concentration in
normal subjects has a fairly well-defined
range between 10 and 200 ng/ml (Jacobs
et al., 1972). It appears to be derived,
either by active or passive release, from
reticuloendothelial cells where it is norm-
ally stored. The concentration is reduced
in iron deficient subjects and is increased
in patieints with iron overload in propor-
tion to the increased amount of storage
iron. The results in Hodgkin's disease are
consistent with the concept of a reticulo-
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endothelial block. Increased concentra-
tions of ferritin in the serum are associated
with a decrease in serum iron and trans-
ferrin saturation. These changes reflect a
shift of iron from the plasma transferrin
pool to thereticuloendothelial ferritin pool.
This shift was most marked in patients
with symptoms of systemic disease.
In acute myeloblastic leukaemia the
reasons for the increased levels of circu-
lating ferritin are not clear. The primary
abnormality oferythropoiesis seems to be a
reduction in red cell production and it is
probable that much of the increase in
serum iron concentration is due to this.
It seems unlikely that the very large
amounts of ferritin found in the serum
reflect reticuloendothelial ferritin in the
same way that appears to be the case in
normal subjects, those with changes in
iron status and those with ain RE block.
Although the transfer of iron from the
red cell compartment into reticuloendo-
thelial stores as a result of anaemia would
be expected to raise the serum ferritin
concentration, there is no evidence in the
data of an inverse relationship between
ferritin concentrations and the circulating
haemoglobin levels. Although a certain
amount ofineffective erythropoiesis might
be expected in many acute leukaemia
patients, the chromatographic charac-
teristics of the circuilating ferritin were
quite different from that derived from
red cells and it is therefore unlikely to be
derived from this source. The possibility
was considered that the excessive amounts
of ferritin in the serum were derived from
the breakdown ofhaemoglobin consequent
upon tissue haemorrhage. There was,
however, no relationship between ferritin
concentration and platelet count and
normal serum ferritin levels were found
in several haemophiliac patients with
tissue haemorrhages. The only clear
relationship in the present data was a
positive correlation between total white
cell count and serum ferritin concentration.
This suggests the possibility that the
circulating ferritin may be derived from
the leukaemic cells themselves and is
consistent with previous observations of
ferritin synthesis by malignant cells. This
phenomenon has been described in rat
hepatoma (Lee and Richter, 1971) and
HeLa cells (Richter, 1965). In the few
patients who were followed up during the
induction of remission by chemotherapy,
ferritin levels did not return to normal
even when the patients were clinically
in full remission, suggesting that some
pathological process remains even at this
stage, possibly associated with a surviving
population of occult leukaemia cells.
It is concluded that the presence of
high circulating concentrations of ferritin
in patients with Hodgkin's disease may
be explained by the presence of an RE
block. The phenomenon may be a useful
index of systemic involvement. In acute
myeloblastic leukaemia the origin of
circulating ferritin and its significance
remain to be elucidated. It is apparent
from the small number of samples exam-
ined from patients with other types of
leukaemia that abnormal ferritinaemia
may sometimes be a characteristic of
these processes also.
We should like to thank the Leukaemia
Research Fund for a grant in support of
this work.
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